Remove 2008 Remove Equities Remove Private Equity
article thumbnail

Trader of the Year Hedge Fund: Conversant Capital’s David Alfred

The TRADE

I spent the first 20 years of my career at the global bulge bracket banks, first in investment banking and then on the institutional equity desks, in a cross-asset and special situations role. I started my career at Bear Stearns in 2001, then migrated to Credit Suisse in 2008. There’s been a reopening in capital markets.

Funds 59
article thumbnail

People Moves Monday: Peel Hunt, Redburn Atlantic, RBC Capital Markets, Citi, and more…

The TRADE

His time at the firm also included a stint in Moscow as treasurer for JP Morgan Moscow from January 2008 to December 2009.   He was also a non-executive director for LCH from 2021 to 2022, as well as a member of the board of directors for the FIA from 2016 to 2022, serving as chair for two years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Great Point Acquires Eutecma

JD Supra: Mergers

Eutecma, founded in 2008 and based in Germany, is a developer of temperature-controlled packaging solutions for pharmaceutical cold chain shipments. Great Point Partners (GPP) has announced the acquisition of a majority stake in Eutecma. By: McGuireWoods LLP

article thumbnail

How the Growth of Private Credit is Impacting Private Equity

OfficeHours

In recent years, private credit has emerged as an important financing source for corporations of all kinds, especially for private equity-owned businesses with high financial leverage. The growth of private credit can be traced back to the Great Financial Crisis of 2008-2009.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: QHP Acquires Applied StemCell

JD Supra: Mergers

Applied StemCell, founded in 2008 and based in Milpitas, Calif., QHP Capital has announced it has acquired Applied StemCell. develops gene editing and stem cell technology platforms designed to help advance broader cell therapy manufacturing. By: McGuireWoods LLP

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Trilantic to Invest in SOFIE Biosciences

JD Supra: Mergers

SOFIE, founded in 2008 and based in Dulles, Virginia, is a radiopharmacy and contract development and manufacturing organization. Trilantic North America announced it will make a growth investment in SOFIE Biosciences. By: McGuireWoods LLP

article thumbnail

Growth Equity: The Child Prodigy of Private Equity and Venture Capital, or an Artifact of Easy Money?

Mergers and Inquisitions

Over the past few decades, growth equity (GE) has gone from an afterthought to a major asset class for huge investment firms. Some argue that GE offers the best of both worlds: the opportunity to fund innovation and growth – as in venture capital – plus the ability to limit downside risk and invest in proven companies – as in private equity.